The global pandemic in 2020 brought significant challenges, as healthcare organizations had to shift their focus to managing COVID-19. While potential customers paused their plans to roll out MCJ, PotentiaMetrics used the time to upgrade its models and expand its dataset. By the end of the year, the company had grown its data to cover over 2 million patients from more than 500 centers, further enhancing the accuracy of its cancer models.